BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
EPS for BioXcel Therapeutics (BTAI)
EPS in 2023 (TTM): -$7.11
According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.11. In 2022 the company made an earnings per share (EPS) of -$5.91 a decrease over its 2021 EPS that were of -$4.08.
EPS history for BioXcel Therapeutics from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$7.11 | 20.3% |
| 2022 | -$5.91 | 44.85% |
| 2021 | -$4.08 | 7.65% |
| 2020 | -$3.79 | 87.62% |
| 2019 | -$2.02 | 51.88% |
| 2018 | -$1.33 | 350.92% |
| 2017 | -$0.29 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -69.34% | 🇺🇸 USA |